Infectious Complications Following Prostate Biopsy: Strategies for Reducing Infections and Reducing Health Care Costs Podcast (2023)
This new AUAUniversity podcast episode will address mechanisms behind infectious complications as well as the health care consequences of infections following prostate biopsy. Faculty will present real world and trial data pertaining to rates and associated factors for infections and provide practical measures to reduce these complications, including transperineal and transrectal approach (standard enema; antibiotic enema; iodine/other rectal prep; needle disinfection).
Project Firstline is a national collaborative led by the U.S. Centers for Disease Control and Prevention (CDC) to provide infection control training and education to frontline health care workers and public health personnel. AMA has partnered with Project Firstline, as supported through Cooperative Agreement CDC-RFA-CK20-2003. The American Urological Association is proud to collaborate with AMA and Project Firstline in this educational activity. CDC is an agency within the Department of Health and Human Services (HHS). The contents of this event do not necessarily represent the policies of CDC or HHS and should not be considered an endorsement by the Federal Government.
Upon completion, participants will be able to:
- Describe health care costs associated with prostate biopsy infections.
- Identify the steps where modifications in technique can reduce the risk of complications.
- Apply modified technique at various steps of the procedures to mitigate the risk of complications.
|Raman, Jay D.
|Nothing relevant to disclose
EDUCATION COUNCIL DISCLOSURES
COI REVIEW WORK GROUP DISCLOSURES
AUA Office of Education Staff has nothing to disclose.
All relevant financial relationships have been mitigated.
AUA ACCREDITATION INFORMATION
Method of Participation: Learners will participate in this online educational activity by listening to the podcast, answering multiple choice questions, examining patient tools and resources and completing the posttest and evaluation. To claim CME credit for this enduring material, learners must complete the posttest, passing with 80% accuracy and submit the program evaluation.
Estimated time to complete this activity: 0.50 hours
Release Date: December, 2023
Expiration Date: December, 2024
Accreditation: The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation: The American Urological Association designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Other Learners: The AUA is not accredited to offer credit to participants who are not MDs or DOs. However, the AUA will issue documentation of participation that states that the activity was certified for AMA PRA Category 1 Credit™.
Evidence Based Content: It is the policy of the AUA to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.
AUA Disclosure Policy: All persons in a position to control the content of an educational activity (i.e., activity planners, presenters, authors) are required to disclose to the provider all financial relationships with any commercial interest (aka ineligible company) during the previous 24 months. The AUA must determine if the individual’s relationships may influence the educational content and mitigate any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.
Mitigation of Identified Conflict of Interest: All disclosures will be reviewed by the AUA Conflict of Interest (COI) Review Work Group Chair and/or Vice Chair for identification of conflicts of interest. The AUA COI Review Work Group, working with Office of Education staff, will document the mechanism(s) for management and mitigation of the conflict of interest and final approval of the activity will be documented prior to implementation.
Off-label or Unapproved Use of Drugs or Devices: The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.
AUA PARTICIPANT INFORMATION & POLICIES
Disclaimer: The opinions and recommendations expressed by faculty, authors and other experts whose input is included in this program are their own and do not necessarily represent the viewpoint of the AUA.
Reproduction Permission: Reproduction of written materials developed for this AUA course is prohibited without the written permission from individual authors and the American Urological Association.
- 0.50 AMA PRA Category 1 Credit™
- 0.50 Non-Physician Participation